Cancer/Tumor Profiling Market Share, Size, Trends, Industry Analysis Report by Technology (Immunoassay, NGS, PCR, In Situ Hybridization, Microarray, Mass Spectrometry, Others); By Biomarker Type (Genomic Biomarkers, Protein Biomarkers, Others); By Cancer Type; By Application; By Regions - Segment Forecast, 2020 - 2027

Report Scope

Cancer Tumor/Profiling Technology Outlook (Revenue, USD Million, 2016 - 2027)

• Immunoassay
• NGS
• PCR
• In Situ Hybridization
• Microarray
• Mass Spectrometry
• Others

Cancer Tumor/Profiling Cancer Type Outlook (Revenue, USD Billion, 2016 - 2027)

• Breast
• 肺
• Colorectal
• Prostate
• Melanoma
• Others

Cancer Tumor/Profiling Biomarker Type Outlook (Revenue, USD Billion, 2016 - 2027)

• Genomic Biomarkers
• Protein Biomarkers
• Others

Cancer Tumor/Profiling Application Outlook (Revenue, USD Billion, 2016 - 2027)

• Personalized Medicine
• Diagnostics
• Prognostics
• Biomarker Discovery
• Research

Cancer Tumor/Profiling Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • India
  • Japan
  • China
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Colombia
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Israel
  • UAE